Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples